(10% Negative) BIOMEA FUSION, INC. (BMEA) Announces Delay in data Trials for type 2 diabetes from which we expect Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review
Walker Mark Stephen 🟡 adjusted position in 1.9K shares (1 derivative) of Forestar Group Inc. (FOR) at $24.29 Transaction Date: Mar 21, 2026 | Filing ID: 020802
Allen James Douglas 🟡 adjusted position in 2.0K shares (1 derivative) of Forestar Group Inc. (FOR) at $24.29 Transaction Date: Mar 21, 2026 | Filing ID: 020801